Anti-parasitic agents, the segment in which Bogar started out, still account for slightly more than 40 per cent of sales. After the introduction of the new biocide directive in this segment, however, the managing director, Peter Hänsli, does not expect to see any further significant innovations here for the time being: "Some suppliers are in for a rough ride. We will see a shake-out in the market."
Bogar believes it is well equipped to face the future. Hänsli says that new categories added in the last few years, such as skin and coat care or dental hygiene, have shown above-average growth and are becoming increasingly important to the company's overall portfolio as a result. Virtually all the products are manufactured in Europe.
"Pet health as a product category is a market of the future," adds Hänsli. The Bogar boss, who spent several years working for Vitakraft, is optimistic about the future. He refers to the greater health awareness of the population and the change in the role of the pet as an established member of the family. "American pet health suppliers showed years ago how to create new trends such as dental hygiene by clear brand positioning and targeted communication. These trends have now arrived in Europe too," he stresses.